Buprenorphine versus methadone maintenance for the treatment of opioid dependence.
about
Opioid agonist treatment for pharmaceutical opioid dependent peopleBuprenorphine maintenance versus placebo or methadone maintenance for opioid dependencePharmacological therapies for maintenance treatments of opium dependenceBuprenorphine maintenance versus placebo or methadone maintenance for opioid dependenceImpact of Chronic Pain on Treatment Prognosis for Patients with Opioid Use Disorder: A Systematic Review and Meta-analysisReduction of opioid dependence by the CB(1) antagonist SR141716A in mice: evaluation of the interest in pharmacotherapy of opioid addictionOpioid Use Disorder in Pregnancy: Health Policy and Practice in the Midst of an Epidemic.Neonatal abstinence syndrome after methadone or buprenorphine exposureBuprenorphine: "field trials" of a new drug.Buprenorphine versus dihydrocodeine for opiate detoxification in primary care: a randomised controlled trial.Process-of-care measures as predictors of client outcome among a methamphetamine-dependent sample at 12- and 36-month follow-ups.Comparison of a drug versus money and drug versus drug self-administration choice procedure with oxycodone and morphine in opioid addicts.Practical considerations for the clinical use of buprenorphine.Impact of treatment approach on maternal and neonatal outcome in pregnant opioid-maintained womenOpioid dependence treatment: options in pharmacotherapy.Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience.Patient perspectives on buprenorphine/naloxone: a qualitative study of retention during the starting treatment with agonist replacement therapies (START) study.Opioid dependence treatment, including buprenorphine/naloxone.The effectiveness of community maintenance with methadone or buprenorphine for treating opiate dependence.Buprenorphine retention in primary care.Timing of buprenorphine adoption by privately funded substance abuse treatment programs: the role of institutional and resource-based interorganizational linkages.Participant characteristics and buprenorphine dose.Comparison of buprenorphine treatment for opioid dependence in 3 settingsBupreorphine:a new pharmacotherapy for opioid addictions treatment.Buprenorphine implants for treatment of opioid dependence: randomized comparison to placebo and sublingual buprenorphine/naloxone.Body Composition Changes Associated With Methadone Treatment.A meta-analysis of retention in methadone maintenance by dose and dosing strategy.Predictors of attrition with buprenorphine/naloxone treatment in opioid dependent youth.Retention in methadone and buprenorphine treatment among African Americans.Induction of pregnant women onto opioid-agonist maintenance medication: an analysis of withdrawal symptoms and study retention.Community-based treatment for opioid dependent offenders: a pilot studyProbuphine® (buprenorphine implant): a promising candidate in opioid dependence.Opiate dependence in schizophrenia: case presentation and literature review.Considerations on the role of buprenorphine in recovery from heroin addiction from a UK perspective.Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: results from a randomized study.Factors associated with buprenorphine versus methadone use in pregnancy.Opioid agonist therapy.Improved quality of life, clinical, and psychosocial outcomes among heroin-dependent patients on ambulatory buprenorphine maintenance.Buprenorphine, buprenorphine/naloxone and methadone maintenance: a cost-effectiveness analysis.Office-based treatment in opioid dependence: a critical survey of prescription practices for opioid maintenance medications and concomitant benzodiazepines in Vienna, Austria.
P2860
Q24185775-15279A87-EFD4-47F1-85C4-62F90C5D5AA5Q24200539-0A4AED3A-64C7-4046-915F-85024EC22591Q24201615-F8086E1F-FB16-4367-A911-C600C5378BD8Q24243180-2C25D79C-23C4-41A3-BB07-E12C4824D5A1Q26785010-B0892570-08B4-4926-94E1-EA22011C45A8Q28363073-E23E8A74-4EB3-4B17-9BDC-A593F74D98D6Q30249760-DDA627BC-891E-47A8-8255-5BEBB0CAF74FQ30499416-AC73285D-04BD-47C2-9A6C-36F0E006B6F6Q31808981-AA7597A9-F4AE-4591-9501-94598D297E31Q33268544-ED354516-6D01-42FD-A835-4637C81A1DC9Q33599881-EC3C9698-945F-48E8-81C3-0B746C65F678Q33751060-DB461F81-F335-45DD-8FA7-3649F876BDE4Q33774853-F7DA61DF-ED91-4CD6-A154-CDC40422867BQ33862878-57D59AD7-3196-4BB3-9277-8E3522A983A4Q33868638-895CB2C4-E6CD-4FFB-9AE7-A47FE2D6028CQ34081656-238F600D-FD66-4076-B819-6D31B2ED84C5Q34452695-A734D0B3-D13C-4A30-A2AE-60476CF0E6CBQ34533873-5E22805F-A849-426E-9D5A-DFC0C09B5CFFQ34620483-241D5D99-36DB-4049-816C-2E8E11A52B83Q34724382-4C0BED52-AA58-48C6-8BA4-45A49D9CF8C7Q35577449-75B62AB8-C646-4F1F-87FF-1CBB20FB10D1Q35738688-4242B90B-1A70-4428-ABB3-7E6F16C08B7DQ35748679-F7B4D72C-34E8-40A9-9A23-8B62281DB5E6Q35886112-9D14C1C6-92DD-4DE7-AD65-2E407FCB516EQ36345193-F7A55CC6-B42B-4EDB-B4F9-932F5B244D44Q36879665-6FC6FAE9-9537-4D25-9592-64AD5C4DB9F0Q36946147-AE770B23-E505-419F-8A9A-6167F741C7D8Q36952763-23F4487F-AD9D-4622-9955-BA282E4D106DQ37022122-A5840AE6-1171-4EF3-B4EE-4009A7FA082AQ37067368-5AD92126-FF2B-41CF-B1E4-0434589ECD3AQ37107672-9ADB12A2-CE4A-4B77-81E1-F8F3E928A6ABQ37705253-D01441C8-30FB-4C69-9908-F54271B71C9BQ38267760-7512CCAA-8EE7-4E04-A30D-41852B0E0FCFQ38562886-22F3C66B-C97A-4E61-B83D-27629A180AB6Q40132985-1FD253D7-D299-4FD1-B979-9301F0584D50Q40777859-B282E54A-84E7-4E3A-8BBA-BD92D894F15EQ42333024-12FB7292-C084-47CD-8567-E8699564ECDBQ43213065-CE8F6FE7-6A49-4497-B689-CAFD36DDD63CQ43266395-0E818D12-620A-4781-96BC-D56926441170Q43751992-6396EB23-7723-4576-AAD1-8245EF05301B
P2860
Buprenorphine versus methadone maintenance for the treatment of opioid dependence.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Buprenorphine versus methadone maintenance for the treatment of opioid dependence.
@en
Buprenorphine versus methadone maintenance for the treatment of opioid dependence.
@nl
type
label
Buprenorphine versus methadone maintenance for the treatment of opioid dependence.
@en
Buprenorphine versus methadone maintenance for the treatment of opioid dependence.
@nl
prefLabel
Buprenorphine versus methadone maintenance for the treatment of opioid dependence.
@en
Buprenorphine versus methadone maintenance for the treatment of opioid dependence.
@nl
P2093
P50
P1433
P1476
Buprenorphine versus methadone maintenance for the treatment of opioid dependence
@en
P2093
P304
P356
10.1046/J.1360-0443.1999.94913376.X
P407
P577
1999-09-01T00:00:00Z